We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Feasibility Study of Docetaxel with Cyclophosphamide as Adjuvant Chemotherapy for Japanese Breast Cancer Patients.
- Authors
Takabatake, Daisuke; Taira, Naruto; Hara, Fumikata; Sien, Tadahiko; Kiyoto, Sachiko; Takashima, Seiki; Aogi, Kenjiro; Ohsumi, Shozo; Doihara, Hiroyoshi; Takashima, Shigemitu
- Abstract
Objective: The 7-year follow-up of the US oncology 9735 trial demonstrated the superiority of TC [docetaxel (DTX)/cyclophosphamide (CPA)] to doxorubicin/CPA therapy. To introduce TC therapy in Japan, the verification of the safety and tolerability is essential. We performed a collaborative prospective safety study with Okayama University to introduce TC therapy.
- Publication
Japanese Journal of Clinical Oncology, 2009, Vol 39, Issue 8, p478
- ISSN
0368-2811
- Publication type
Article
- DOI
10.1093/jjco/hyp050